Lung Cancer Canada and Boehringer Ingelheim Canada announce collaboration to advance innovation in Non-Small Cell Lung Cancer diagnostics
Lung Cancer Canada (LCC) and Boehringer Ingelheim Canada (Boehringer) are pleased to announce a new collaboration aimed at reimagining detection and accelerating innovation in non-small cell lung cancer (NSCLC) diagnostics. This partnership reflects a shared commitment to advancing earlier diagnosis and improving outcomes for Canadians affected by lung cancer. Lung cancer remains the most commonly […]